S&P 500   4,288.67 (+0.01%)
DOW   33,447.31 (-0.18%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.67 (+0.01%)
DOW   33,447.31 (-0.18%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.67 (+0.01%)
DOW   33,447.31 (-0.18%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
S&P 500   4,288.67 (+0.01%)
DOW   33,447.31 (-0.18%)
QQQ   357.55 (-0.20%)
AAPL   171.12 (-0.05%)
MSFT   315.68 (-0.02%)
META   300.70 (+0.16%)
GOOGL   130.31 (-0.42%)
AMZN   126.90 (-0.17%)
TSLA   240.58 (-3.85%)
NVDA   438.16 (+0.73%)
NIO   8.92 (-1.33%)
BABA   86.75 (+0.01%)
AMD   102.65 (-0.17%)
T   15.01 (-0.07%)
F   12.34 (-0.64%)
MU   68.03 (+0.00%)
CGC   0.78 (-0.97%)
GE   110.00 (-0.50%)
DIS   80.82 (-0.28%)
AMC   8.05 (+0.75%)
PFE   33.13 (-0.12%)
PYPL   58.65 (+0.33%)
NFLX   377.00 (-0.16%)
NYSE:AVTR

Avantor (AVTR) Stock Forecast, Price & News

$21.08
+0.29 (+1.39%)
(As of 09/29/2023 06:40 PM ET)
Compare
Today's Range
$21.00
$21.42
50-Day Range
$20.22
$23.34
52-Week Range
$17.91
$25.25
Volume
4.12 million shs
Average Volume
6.34 million shs
Market Capitalization
$14.25 billion
P/E Ratio
33.46
Dividend Yield
N/A
Price Target
$25.93

Avantor MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
23.0% Upside
$25.93 Price Target
Short Interest
Healthy
2.50% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.59mentions of Avantor in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$693,139 Sold Last Quarter
Proj. Earnings Growth
14.02%
From $1.07 to $1.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.60 out of 5 stars

Medical Sector

123rd out of 968 stocks

Analytical Instruments Industry

8th out of 29 stocks


AVTR stock logo

About Avantor (NYSE:AVTR) Stock

Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Price History

AVTR Stock News Headlines

Check Out What Whales Are Doing With AVTR
Avantor (NYSE:AVTR) PT Raised to $25.00 at Barclays
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
Sanford C. Bernstein Initiates Coverage on Avantor (NYSE:AVTR)
Expert Ratings for Avantor
Avantor® Announces New Scientific Advisory Board
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Avantor (AVTR) Receives a Buy from RBC Capital
Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Analyst Expectations for Avantor's Future
Avantor (AVTR) Receives a Buy from Barclays
Citi Keeps Their Buy Rating on Avantor (AVTR)
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Company Calendar

Last Earnings
7/28/2023
Today
10/02/2023
Next Earnings (Confirmed)
10/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$25.93
High Stock Price Forecast
$33.00
Low Stock Price Forecast
$21.00
Forecasted Upside/Downside
+23.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$686.50 million
Pretax Margin
7.49%

Debt

Sales & Book Value

Annual Sales
$7.51 billion
Cash Flow
$2.04 per share
Book Value
$7.20 per share

Miscellaneous

Free Float
665,779,000
Market Cap
$14.25 billion
Optionable
Not Optionable
Beta
1.29
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael  StubblefieldMr. Michael Stubblefield (Age 50)
    Pres, CEO & Director
    Comp: $1.15M
  • Dr. Gerard Brophy Ph.D. (Age 57)
    Exec. VP of Biopharma Production
    Comp: $579.47k
  • Mr. Frederic  VanderhaegenMr. Frederic Vanderhaegen (Age 56)
    Exec. VP of Europe
    Comp: $666.12k
  • Ms. Sheri Lewis (Age 57)
    Exec. VP of Global Supply Chain
    Comp: $490.62k
  • Mr. R. Brent Jones (Age 53)
    Exec. VP & CFO
  • Mr. Steven W. EckMr. Steven W. Eck (Age 46)
    Sr. VP, Corp. Controller & Chief Accounting Officer
  • Mr. Michael  WondraschMr. Michael Wondrasch (Age 54)
    Exec. VP & Chief Information Officer
  • Mr. Tommy J. Thomas CPA
    VP of Investor Relations
  • Mr. Claudius O. Sokenu (Age 55)
    Exec. VP, Corp. Sec. and Chief Legal & Compliance Officer
  • Ms. Allison K. Hosak
    Sr. VP of Global Communications & Brand













AVTR Stock - Frequently Asked Questions

Should I buy or sell Avantor stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings
or view top-rated stocks.

What is Avantor's stock price forecast for 2023?

13 brokers have issued 1 year price targets for Avantor's stock. Their AVTR share price forecasts range from $21.00 to $33.00. On average, they predict the company's stock price to reach $25.93 in the next year. This suggests a possible upside of 23.0% from the stock's current price.
View analysts price targets for AVTR
or view top-rated stocks among Wall Street analysts.

How have AVTR shares performed in 2023?

Avantor's stock was trading at $21.09 at the start of the year. Since then, AVTR stock has decreased by 0.0% and is now trading at $21.08.
View the best growth stocks for 2023 here
.

Are investors shorting Avantor?

Avantor saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 16,930,000 shares, an increase of 27.5% from the August 31st total of 13,280,000 shares. Based on an average daily trading volume, of 5,510,000 shares, the days-to-cover ratio is presently 3.1 days.
View Avantor's Short Interest
.

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our AVTR earnings forecast
.

How can I listen to Avantor's earnings call?

Avantor will be holding an earnings conference call on Friday, October 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) posted its quarterly earnings data on Friday, July, 28th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.29 by $0.01. The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.80 billion. Avantor had a trailing twelve-month return on equity of 17.00% and a net margin of 5.89%. The business's revenue for the quarter was down 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 earnings per share.

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $1.04-$1.12 for the period, compared to the consensus earnings per share estimate of $1.16. The company issued revenue guidance of $6.89 billion-$7.04 billion, compared to the consensus revenue estimate of $7.08 billion.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

When did Avantor IPO?

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

What is Avantor's stock symbol?

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avantor's stock price today?

One share of AVTR stock can currently be purchased for approximately $21.08.

How much money does Avantor make?

Avantor (NYSE:AVTR) has a market capitalization of $14.25 billion and generates $7.51 billion in revenue each year. The company earns $686.50 million in net income (profit) each year or $0.63 on an earnings per share basis.

How many employees does Avantor have?

The company employs 14,500 workers across the globe.

How can I contact Avantor?

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The official website for the company is www.avantorsciences.com. The company can be reached via phone at (610) 386-1700 or via email at avantorir@avantorsciences.com.

This page (NYSE:AVTR) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -